Yongin-si, South Korea

Hoyong Lim


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):

Title: Hoyong Lim: Innovator in Cancer Treatment

Introduction

Hoyong Lim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.

Latest Patents

Hoyong Lim holds three patents, with his latest focusing on an anti-HER2 antibody or antigen-binding fragment thereof. This invention is crucial for the prevention or treatment of cancer, particularly targeting HER2, which is highly expressed in breast and gastric cancer cells. The antibody binds to a unique epitope, differentiating it from existing treatments like trastuzumab.

Career Highlights

Hoyong Lim is associated with Gc Cell Corporation, where he continues to advance his research in cancer therapies. His work has the potential to improve treatment outcomes for patients suffering from HER2-positive cancers.

Collaborations

Hoyong Lim collaborates with notable colleagues, including Jong Seo Lee and Kyu Tae Kim, to further enhance the development of innovative cancer treatments.

Conclusion

Hoyong Lim's contributions to cancer research through his patents and collaborations highlight his role as a key innovator in the medical field. His work promises to pave the way for more effective cancer therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…